Live Breaking News & Updates on Femoropopliteal Disease With|Page 1

Stay updated with breaking news from Femoropopliteal disease with. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Final Round of Late-Breaking Clinical Trial Results Announced at VIVA22

/PRNewswire/ The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and. ....

United States , Christopherj Kwolek , Wynn Las Vegas , Danielj Bertges , Ehrinj Armstrong , Maureenp Kohi , Tjuny Tang , Boston Scientific Corporation Deds , Society Consensus , Vascular Quality Initiative , Society For Vascular Surgery , Late Breaking Clinical Trials , Wynn Las , Vascular Interventional Advances , Fixated Endograft Has Similar Outcomes , Year Results , Primary Analysis , Randomized Data , Sirolimus Drug Eluting Balloons , Complex Below The Knee Atherosclerotic Disease , Patients With Chronic Limb Threatening Ischemia , Month Results From , Walking Impairment Questionnaire , Mean Rutherford , Increasing Diversity , Peripheral Artery Disease ,

Final Round of Late-Breaking Clinical Trial Results Announced at VIVA22

/PRNewswire/ The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and. ....

United States , Christopherj Kwolek , Wynn Las Vegas , Danielj Bertges , Ehrinj Armstrong , Maureenp Kohi , Tjuny Tang , Boston Scientific Corporation Deds , Society Consensus , Vascular Quality Initiative , Society For Vascular Surgery , Late Breaking Clinical Trials , Wynn Las , Vascular Interventional Advances , Fixated Endograft Has Similar Outcomes , Year Results , Primary Analysis , Randomized Data , Sirolimus Drug Eluting Balloons , Complex Below The Knee Atherosclerotic Disease , Patients With Chronic Limb Threatening Ischemia , Month Results From , Walking Impairment Questionnaire , Mean Rutherford , Increasing Diversity , Peripheral Artery Disease ,

Late-breaking Clinical Trial presentations announced for The VEINS and VIVA Conference

Details on late-breaking clinical trials to be presented during The VEINS (Venous Endovascular INterventional Strategies) and VIVA (Vascular InterVentional Advances) Annual Conference have been announced. Leading physicians and researchers will present results from 21 clinical trials, from Monday, October 31, to Wednesday, November 2, at Wynn Las Vegas. ....

Kenneth Rosenfield , Wynn Las Vegas , Elias Iliadis , Tjun Tang , Sean Lyden , Christopher Kwolek , Thomas Maldonado , Michael Lichtenberg , Ido Weinberg , Prakash Krishnan , Surendra Shenoy , David Dexter , Daniel Bertges , Ehrin Armstrong , John Filtes , Steven Abramowitz , Mehdi Shishehbor , Maureen Kohi , Peter Soukas , Venous Endovascular , Annual Conference , Wynn Las , Breaking Clinical Trial , Clinical Trials , Clinical Outcomes , Initial Clinical Presentation Through ,

First-on-Podium Data from 21 Vascular Interventional Clinical Trials to Be Presented at The VEINS and VIVA 2022

/PRNewswire/ Leading physicians and researchers will present results from 21 clinical trials from Monday, October 31, to Wednesday, November 2, at the. ....

Kenneth Rosenfield , Wynn Las Vegas , Elias Iliadis , Tjun Tang , Sean Lyden , Christopher Kwolek , Thomas Maldonado , Michael Lichtenberg , Ido Weinberg , Prakash Krishnan , Surendra Shenoy , David Dexter , Daniel Bertges , Ehrin Armstrong , John Filtes , Steven Abramowitz , Mehdi Shishehbor , Maureen Kohi , Peter Soukas , Wynn Las , Vascular Interventional Advances , Venous Endovascular , Clinical Outcomes , Initial Clinical Presentation Through , Treated With , Human Study Results With Amplifi ,